This is a blatant lie.8. This narrative may lead them to believe the condition cannot be influenced by approaches based on a biopsychosocial approach, which is clearly helping many people to reduce symptoms and some to recover.
This is a blatant lie.10. The article states there are no effective treatments, but this is incorrect. There are a range of strategies for rehabilitation, drawing on the biopsychosocial explanation of this condition. These include cognitive behaviour therapy, approaches to safely increase activity and mind-body approaches. The research indicates these options may help people reduce symptoms and ensure some recover. Putting patients on hold with this condition awaiting a drug could be unhelpful.
I wonder if COFFI could propose a way to recruit and verify both the diagnosis and subsequent recovery of a sufficiently large amount of recovered ME/CFS patients. This is like asking NASA why they don’t just teleport to Mars instead of using spaceships.11. We also know that recovery is possible, and question why recovered patients were not included in the genetic analysis. Maybe this is a question to be added in further research. It would be interesting to know whether genetic, environmental, or psychological factors influencing the occurrence, severity and chance of recovery.
This completely misses the point about genes always being causal, and always pointing towards disease mechanisms. It also misses the point about the effect of treatments being largely independent of the effect size of the genes the treatments were based on.15. We note that the eight genetic markers reported in the pre-print were associated with the condition, but the size of the effect found were modest. This means that the same genetic markers were also present in many healthy control participants. This makes their isolated interpretation limited. Further analysis looking at various gene combinations may be more informative.
It was based on self report of a diagnosis by an HCP and fulfilment of the diagnostic criteria based on questionnaires.18. We note that the ME/CFS diagnosis was based on self-report.
COFFI doesn't understand GWAS. They are based on studying common SNPs, so inevitably, they will be present in healthy controls at very similar rates. The goal is not find to the genes with largest impact, but to identify the regions associated with the disease. This permits more precise study. That these common SNPs have little individual impact is irrelevant because drugs targeting the exact mechanisms can have very large impact.We note that the eight genetic markers reported in the pre-print were associated with the condition, but the size of the effect found were modest. This means that the same genetic markers were also present in many healthy control participants. This makes their isolated interpretation limited. Further analysis looking at various gene combinations may be more informative.
20. In summary, this large study has some interesting findings with specific genes identified. This is a contribution to what we know already, and needs replication.
The complete lack of integrity these people are showing is truly excessive. A million toilets being flushed will never produce this much poop mist.Response to DecodeME Preprint
Statement from researchers and consumers from the Collaborative on Fatigue and related symptoms Following Infection (COFFI)
7. Genes are part of the picture, but there is a danger with this emphasis.
The statement “we see it in the blood” implies for consumers that genes “cause” the condition.
So at point7 it gets all Garnerish and doesn’t make sense, so I stopped readingThis statement may contribute to some patients believing nothing can be done unless we get a biomedical cure.
I stopped counting very early, and it went on and on.This is a blatant lie.
Okay, so this was a self-report of a healthcare professional diagnosis, supported by the DecodeME criteria, which required post-exertion malaise, a symptom pretty specific for ME/CFS. So, a fairly well defined cohort. But had it been varied, that would make it more likely to find nothing, not to find false positives. They don't seem to have a very good grasp of GWAS or wider issues.18. We note that the ME/CFS diagnosis was based on self-report. This means the patients will be quite varied, and only a small minority reported onset with a documented infection, whereas fatigue conditions can arise because of many different precipitating causes. This wide variation in the patients may well lead to flawed positive associations with genes that have no influence; and on the other hand, may miss actual associations.
COFFI said:only a small minority reported onset with a documented infection, whereas fatigue conditions can arise because of many different precipitating causes.
Are they referring to something else when they say "small minority"? 63% is clearly not a minority.DecodeME found 63% had self-reported infectious onset. Other studies find a higher rate, but DecodeME used a better question, allowing "don't know" as an answer.
It's not clear what it even means.They refer to "documented" infection.
Participants were asked if the infection for either infectious mononucleosis (glandular fever) or Covid had been confirmed by a test. For mono, this would be a lab test, which is often done in severe cases. I can't remember if the Covid question includes the option includes a home test.Are they referring to something else when they say "small minority"? 63% is clearly not a minority.
They refer to "documented" infection. Is there data on what proportion of these infections in DecodeME were "documented"?
DecodeME really is groundbreaking. It's the first bite of the cake.
At least the Norwegian members of COFFI argue for fatigue being a spectrum, with CFS on the extreme end. So I'd say they don't see a difference between ME and other fatigue.But DecodeME is studying ME/CFS. I'm not sure they realise there's a difference between ME/CFS and all fatiguing conditions.
a biopsychosocial approach, which is clearly helping many people to reduce symptoms and some to recover.
There are a range of strategies for rehabilitation, drawing on the biopsychosocial explanation of this condition. These include cognitive behaviour therapy, approaches to safely increase activity and mind-body approaches. The research indicates these options may help people reduce symptoms and ensure some recover.